Global Cancer Cases Could Reach 35 Million a Year by 2050, Report Warns

Global cancer cases are expected to rise sharply as populations grow and age, placing unprecedented pressure on healthcare systems worldwide. A new international report warns that cancer services could be overwhelmed by 2050 unless countries act urgently to expand and reorganize their medical workforce.

The Lancet Oncology Commission projects that 35.3 million people will be diagnosed with cancer each year by mid-century, while annual cancer deaths could reach 18.5 million. Around 70% of those diagnosed are expected to live in low- and middle-income countries, where access to timely diagnosis and treatment is already limited.

Severe Global Staffing Shortfalls

The commission, led by experts from Memorial Sloan Kettering Cancer Center and Indiana University, estimates a global shortfall of approximately 100 million cancer-related healthcare workers by 2050.

The largest projected gaps are in nursing and diagnostic professions, including radiologists and pathologists who play a critical role in early and accurate cancer detection.

According to the report, the world will need an additional 65 million nurses involved in cancer care. Researchers also identified a need for 16 million more diagnostic specialists, alongside millions of additional technical and allied healthcare professionals trained to support imaging, radiotherapy, and laboratory services.

The study also highlights major shortages among highly trained physicians. It forecasts a global gap of 10 million specialist doctors requiring at least a decade of training, as well as a further shortage of 6 million advanced clinical specialists with 6 to 10 years of education.

Without significant expansion of training programs, many countries may struggle to provide comprehensive cancer care.

Deep Inequality in Survival Prospects

The commission warns that existing disparities between regions are likely to widen if current trends continue.

By 2050, five-year net cancer survival is projected to reach only 34% in Africa and 39% in Asia, compared with approximately 60% in high-income regions such as North America and Oceania.

Researchers estimate that one in three cancer cases worldwide currently goes undiagnosed. The problem is particularly severe in parts of Africa, where more than 60% of cancers may never be formally detected.

In many regions, survival depends less on the biology of the tumor and more on where a patient lives and receives care.

Delays in diagnosis, limited pathology services, and poor access to imaging frequently result in cancers being detected at later stages, when treatment is more difficult and outcomes are worse.

The authors emphasize that without major investment in workforce development and healthcare infrastructure, the gap in cancer survival between wealthier and poorer countries will continue to grow.

Strategies to Prevent a Global Crisis

To address the projected shortages, the commission proposes several strategies aimed at strengthening cancer care systems.

These include country-specific workforce plans, more efficient use of existing staff, expanded task-sharing with trained non-physician providers, and broader adoption of digital technologies and artificial intelligence for diagnostics and care coordination.

One major recommendation is the creation of a global cancer workforce registry that would systematically track staffing levels, training capacity, and skills shortages around the world.

Researchers argue that such a system could help governments and international organizations make more informed decisions about education, recruitment, and workforce retention.

The report also calls for stronger collaboration between countries, healthcare institutions, and private organizations to support training, research, and access to modern medical technologies.

Investment in telemedicine and AI-assisted image analysis could help extend specialist expertise to underserved regions where access to cancer care remains limited.

The Economic Case for Investment

Economists working with the commission estimate that expanding the global cancer workforce and related healthcare systems could prevent approximately 170 million deaths between 2030 and 2050.

They calculate that every US$1 invested could generate around US$4 in economic and social benefits, producing an estimated US$120 trillion in value over the next two decades.

Commission members warn that time is running short. Because training new specialists often takes many years, decisions made during this decade will strongly influence cancer outcomes by mid-century.

The authors describe their findings as a final warning, arguing that failure to act now could leave millions facing preventable deaths in the future.

The report, published in The Lancet Oncology, adds to a growing body of evidence showing that healthcare workforce capacity is one of the most important determinants of cancer survival. Researchers hope its recommendations will be incorporated into future global health initiatives and national cancer control strategies.